<DOC>
	<DOCNO>NCT02250573</DOCNO>
	<brief_summary>The main objective study investigate safety efficacy Replenine®-VF administer appropriate dosage bolus infusion prevent bleed achieve haemostasis subject haemophilia B undergoing surgery .</brief_summary>
	<brief_title>An Open-study Investigate Safety Efficacy Replenine®-VF Haemophilia B Subjects Undergoing Surgery</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Hemophilia B</mesh_term>
	<criteria>Subjects moderate severe haemophilia B undergoing major surgery require inpatient stay generally 5 10 day .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>